Abbreviations ADVANCE: action in diabetes and vascular disease AMI: acute myocardial infarction BID: twice daily bpm: beats per minute CI: confidence interval CVOT: cardiovascular outcome trial ELIXA: Evaluation of LIXisenatide in Acute coronary syndrome FIGHT: Functional Impact of GLP-1 for Heart Failure Treatment GLP-1 RA: glucagon-like peptide-1 receptor agonist HF: heart failure HR: heart rate LAR: long-acting release LEADER: Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results LIVE: Effect of LIraglutide on left VEntricular function in chronic heart failure patients with and without type 2 diabetes LS: least squares PK: pharmacokinetic QD: once daily QW: once weekly SE: standard error T2DM: type 2 diabetes mellitus References Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, Peters AL, Tsapas A, Wender R, Matthews DR

The medicine is taken once weekly , with dose changes guided by your prescriber, typically in four-week intervals from 2.5 mg towards a maintenance dose up to 15 mg when suitable
Compounded tirzepatide drops to $219 a month on a three-month plan and $199 a month on a six-month plan
GLP-1 weight loss injections offer a discreet, medically supervised way to improve body composition while supporting long-term health
EllieMD does not assume liability for decisions made based on the information presented in this video
A: Insurers still use BMI because it gives them a quick, standard way to decide who may qualify for treatments like weight-loss surgery